Washington Report
Comparative Effectiveness Research: Challenges for Pharma
Switching Rx drugs to OTC and adding comparative data could broaden access to treatment, writes Pharm Exec's Washington correspondent Jill Wechsler
...Read more

Advertisement Establishing Case Quality Metrics - defining and using quality metrics for adverse event case processing. Measurement of case quality in pharmacovigilance is a relatively new development. Until pharmaceutical companies began outsourcing their case processing operations, the only measure of effectiveness of their internal operations was compliance with regulatory reporting timelines. Now that these operations are performed by vendors, over the last two years vendor management organizations within pharmaceutical companies and Health Authorities have come up with a way to measure the "quality" of Adverse Event (AE) cases. This paper captures our experience and learning in defining and using case quality metrics while working with large and small pharmaceutical companies. http://www.sciformix.com/Establishing.php

Digital Pharma
Using Social Networks to Improve Sales
Social networks existed long before Mark Zuckerberg came along. What hasn't existed until recently are the tools, metrics and case studies necessary to understand how physicians influence each other within professional networks ...Read More

Case Study: How a Biotech Saved $600,000 on a CRO Contract Download a new case study to discover how a small biotech applied innovative eClinical software to: * Save $600,000 on a single Phase II outsourcing contract * Compress the contracting cycle-time from three months to two weeks * Form a more constructive and collaborative working relationship with their CRO Download Now

Digital Pharma
Going the Distance in Digital Advertising
For pharma, simply moving traditional marketing materials and tactics from print to online is not enough — a true digital transition must be interactive to be effective writes Jennifer Ringler ...Read More

Big Pharma
CETP Inhibitors: Blockbusters That Never Ran?
The news that Roche scrapped development on its CETP inhibitor dalcetrapib, a drug designed to raise HDL cholesterol in the blood, likely presages the shuttering of Lilly's development program for its CETP inhibitor, evacetrapib, industry experts and analysts say ...Read more

Advertisement Adam Smith Conferences' Russian Pharmaceutical Forum (22-24 May, St. Petersburg, Russia) - the biggest industry event of the year, with over 500 senior executives representing all the leading international and local pharmaceutical companies, distributors, retail chains, gathering to attend to discuss all the burning questions of the day, to compare experiences and share ideas for the future. Get involved – REGISTER TO ATTEND at https://www.adamsmithconferences.com/hr21pebw

Regulatory
Drug Shortages Still in Focus
Drug shortages took center stage last year. Progress has been made, but Congress is evaluating if additional steps need to be taken, writes Patricia Van Arnum ...Read more

Abbott Requests Indefinite Protection from Biosimilars Competition

Sanofi Ireland Site Receives Approval

Pharma in Poland